Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gopal

Showing results (271-280 of 429) with videos related to

Pageof 43
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular LymphomaChaitra Ujjani, Hongkun Wang, Catherine Broome, et al.
British Journal of Haematology|April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Blood Advances|January 10, 2024
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinicRahul Banerjee, Christina Poh, Alexandre V Hirayama, et al.
Blood Neoplasia|June 19, 2026
Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphomaLorenzo Iovino, Ningxin Ma, Mohamed A Kharfan-Dabaja, et al.
British Journal of Haematology|October 10, 2025
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphomaRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Molecular Cancer Therapeutics|July 3, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell LymphomasJohnnie J Orozco, Manuela C Matesan, Sally J Lundberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancyA K Gopal, V G Fowler, M Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk LymphomaRyan D Cassaday, Oliver W Press, John M Pagel, et al.
Pageof 43

Showing results (271-280 of 429) with videos related to

Sort By:
Pageof 43
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular LymphomaChaitra Ujjani, Hongkun Wang, Catherine Broome, et al.
British Journal of Haematology|April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Blood Advances|January 10, 2024
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinicRahul Banerjee, Christina Poh, Alexandre V Hirayama, et al.
Blood Neoplasia|June 19, 2026
Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphomaLorenzo Iovino, Ningxin Ma, Mohamed A Kharfan-Dabaja, et al.
British Journal of Haematology|October 10, 2025
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphomaRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Molecular Cancer Therapeutics|July 3, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell LymphomasJohnnie J Orozco, Manuela C Matesan, Sally J Lundberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancyA K Gopal, V G Fowler, M Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk LymphomaRyan D Cassaday, Oliver W Press, John M Pagel, et al.
Pageof 43